Literature DB >> 8380901

Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP).

A I Bhigjee1, P L Bill, C A Wiley, I M Windsor, D A Matthias, T Amenomori, W Wachsman, D Moorhouse.   

Abstract

Peripheral nerve dysfunction (PND) was found in as many as 43% of our patients with human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM/TSP). To evaluate the PND further we biopsied the sural nerve in 6 patients. The histological features were varying degrees of demyelination, remyelination, axonal atrophy and degeneration, and perineurial fibrosis. "Globule" or "sausage" formation was prominent in two of the specimens. Inflammatory infiltrates were absent. No deposits of IgG, IgM, IgA, or complement were detected in the biopsies. No viral antigen or proviral DNA was detected. It is proposed that the PND and the histological findings noted are part of HTLV-I-associated disease and not an unrelated disorder. The pathogenesis of the PND remains unclear. There was no evidence of direct viral infection. The histological findings could represent primary changes induced by viral-triggered release of soluble factors, such as cytokines or secondary changes to more proximal disease, e.g., root involvement.

Entities:  

Mesh:

Year:  1993        PMID: 8380901     DOI: 10.1002/mus.880160106

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.

Authors:  Alberto R M Martinez; Raphael F Casseb; Carlos R Martins; Anamarli Nucci; Marcondes C França
Journal:  J Neurovirol       Date:  2018-01-09       Impact factor: 2.643

Review 2.  Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum.

Authors:  P E Rodgers-Johnson
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

3.  Clinicopathological and virological analyses of familial human T-lymphotropic virus type I--associated polyneuropathy.

Authors:  Hirofumi Sawa; Toshiko Nagashima; Kazuo Nagashima; Toshiya Shinohara; Takayo Chuma; Yukio Mano; Nobutada Tachi; William W Hall
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

4.  Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy.

Authors:  Ana C C Leite; Marcus Tulius T Silva; Alexandre H Alamy; Cristiane R A Afonso; Marco A D Lima; Maria J Andrada-Serpa; Osvaldo J M Nascimento; Abelardo Q-C Araújo
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

5.  Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls.

Authors:  M T T Silva; P Mattos; A Alfano; A Q-C Araújo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

6.  High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells.

Authors:  S Kushida; H Mizusawa; M Matsumura; H Tanaka; Y Ami; M Hori; K Yagami; T Kameyama; Y Tanaka; A Yoshida
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 7.  Notes on the Recent History of Neuroscience in Africa.

Authors:  Vivienne A Russell
Journal:  Front Neuroanat       Date:  2017-11-07       Impact factor: 3.856

8.  Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectives.

Authors:  Mineki Saito; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2012-02-06

Review 9.  Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito
Journal:  J Neurovirol       Date:  2013-08-14       Impact factor: 3.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.